Ahead of an FDA meeting on COVID vaccine boosters, Pfizer submitted a study suggesting vaccine efficacy fades over time naturally, irrespective of variant
In new documents, Pfizer cited data showing a third dose of its vaccine boosted protection for older adults in Israel back up to about 95 percent. However, FDA regulators remain skeptical of the need for boosters in the first place.
As pharmaceutical companies and some health agencies continue their push for COVID-19 vaccine booster shots, a group of leading American and international scientists have concluded that boosters [.]
How Fauci and the NIH got ahead of the FDA and CDC in backing boosters news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.